Literature DB >> 30066911

Mesothelial cells facilitate cancer stem‑like properties in spheroids of ovarian cancer cells.

Akemi Shishido1, Seiji Mori2, Yuhki Yokoyama1, Yoshinosuke Hamada1, Kazumasa Minami3, Yamin Qian1, Jiaqi Wang1, Haruka Hirose1, Xin Wu1, Naomasa Kawaguchi1, Sachiko Nagumo1, Nariaki Matsuura1, Hirofumi Yamamoto1.   

Abstract

Ovarian cancer is characterized by widespread peritoneal dissemination with ascites. Spheroids observed in the ascites of ovarian cancer patients are a mixture of cancer cells and mesothelial cells. In the present study, we evaluated whether mesothelial cells exfoliated from the peritoneum facilitate tumor spheroid formation and give rise to cancer stem‑like properties in ovarian cancer cells. Spheroids from the CAOV3 and A2780 ovarian cancer cell lines grew much larger in co‑culture with mesothelial cells than in monoculture under 3D conditions. The spheroids in co‑culture displayed high Ki‑67 expression in the peripheral zone and low expression in the central zone area. The expression of CD133 emerged in the inner portion of spheroids at later time‑points (96 and 168 h), indicating that cancer cells expanded to the inner spheroid and acquired stem cell‑properties. The mRNA levels of cancer stem cell markers Dclk‑1, CD44 and Bmi‑1 significantly increased in co‑cultured CAOV3 and mesothelial cells compared to CAOV3 cells alone. Furthermore, the mesothelial cells promoted the tumorigenesis and growth of the CAOV3 cells in a mouse xenograft model compared to cancer cells alone. In conclusion, mesothelial cells promoted spheroid formation by ovarian cancer cells and facilitated cancer stem‑like properties.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30066911     DOI: 10.3892/or.2018.6605

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

Review 1.  Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model.

Authors:  Eric N Horst; Michael E Bregenzer; Pooja Mehta; Catherine S Snyder; Taylor Repetto; Yang Yang-Hartwich; Geeta Mehta
Journal:  Acta Biomater       Date:  2021-04-30       Impact factor: 10.633

Review 2.  Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase.

Authors:  Laurie G Hudson; Jennifer M Gillette; Huining Kang; Melanie R Rivera; Angela Wandinger-Ness
Journal:  Cancers (Basel)       Date:  2018-09-27       Impact factor: 6.639

3.  Tumor cell‑fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer.

Authors:  Qing Han; Bangxing Huang; Zaiju Huang; Jing Cai; Lanqing Gong; Yifan Zhang; Jiahong Jiang; Weihong Dong; Zehua Wang
Journal:  Int J Mol Med       Date:  2019-10-02       Impact factor: 4.101

4.  Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.

Authors:  Fumihiko Matsuzawa; Hirofumi Kamachi; Tatsuzo Mizukami; Takahiro Einama; Futoshi Kawamata; Yuki Fujii; Moto Fukai; Nozomi Kobayashi; Yutaka Hatanaka; Akinobu Taketomi
Journal:  BMC Cancer       Date:  2021-02-26       Impact factor: 4.430

5.  Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis.

Authors:  Danila Del Rio; Ilenia Masi; Valentina Caprara; Francesca Spadaro; Flavia Ottavi; Raffaele Strippoli; Pilar Sandoval; Manuel López-Cabrera; Ricardo Sainz de la Cuesta; Anna Bagnato; Laura Rosanò
Journal:  Front Cell Dev Biol       Date:  2021-12-01

6.  Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment.

Authors:  Tyvette S Hilliard; Brooke Kowalski; Kyle Iwamoto; Elizabeth A Agadi; Yueying Liu; Jing Yang; Marwa Asem; Yuliya Klymenko; Jeff Johnson; Zonggao Shi; Gifty Marfowaa; Madeleine G Yemc; Phillip Petrasko; M Sharon Stack
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

Review 7.  Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.

Authors:  Sandra Muñoz-Galván; Amancio Carnero
Journal:  Cells       Date:  2020-06-04       Impact factor: 6.600

8.  Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A.

Authors:  Hua Guo; Chunfang Ha; Hui Dong; Zhijuan Yang; Yuan Ma; Yonghui Ding
Journal:  Cancer Cell Int       Date:  2019-12-21       Impact factor: 5.722

9.  Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells.

Authors:  Laura R Moffitt; Maree Bilandzic; Amy L Wilson; Yiqian Chen; Mark D Gorrell; Martin K Oehler; Magdalena Plebanski; Andrew N Stephens
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

10.  BMI-1 Expression Heterogeneity in Endometriosis-Related and Non-Endometriotic Ovarian Carcinoma.

Authors:  Ludmila Lozneanu; Raluca Anca Balan; Ioana Păvăleanu; Simona Eliza Giuşcă; Irina-Draga Căruntu; Cornelia Amalinei
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.